Drug-specific risk of severe QT prolongation following acute drug overdose

References

• Center for Behavioral Health Statistics and Quality. 2016 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMHSA). Published September 7, 2017. [cited 2019 Mar 5]. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013. [cited 2019 Mar 5]. Available from: https://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf
   Google Scholar
• Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002-12. Health Aff (Millwood)). 2016;35(5):832–837.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD. Published July 2, 2012. [cited 2018 Nov 14]. https://www.samhsa.gov/data/sites/default/files/DAWN096/DAWN096/SR096EDHighlights2010.htm.
   Google Scholar
• National Institute on Drug Abuse. Drug-related emergency room visits. Revised May 2011. [cited 2018 Nov 14]. Available from: https://www.drugabuse.gov/publications/drugfacts/drug-related-hospital-emergency-room-visits.
   Google Scholar
• Manini AF, Nelson LS, Stimmel B, et al. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012;19(7):843–849.
   PubMed Web of Science ®Google Scholar
• Manini AF, Hoffman RS, Stimmel B, et al. Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Acad Emerg Med. 2015;22(5):499–507.
   PubMed Web of Science ®Google Scholar
• Manini AF, Nair AP, Vedanthan R, et al. Validation of the prognostic utility of the electrocardiogram for acute drug overdose. J Am Heart Assoc. 2017;6(2):e004320.
   PubMed Web of Science ®Google Scholar
• Manini AF, Nelson LS, Skolnick AH, et al. Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning. J Med Toxicol. 2010;6(2):106–115.
   PubMedGoogle Scholar
• Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC Case Registry Investigators. ACMT ToxIC case registry investigators. The toxicology investigators consortium (ToxIC) registry. J Med Toxicol. 2011;7(4):259–265.
   PubMedGoogle Scholar
• Farrugia L, Rhyee S, Campleman SL, et al. The toxicology investigators consortium case registry—the 2017 annual report. J Med Toxicol. 2018;14(3):182–211.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Arts DG, De Keizer NF, Scheffer GJ. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc. 2002;9(6):600–611.
   PubMed Web of Science ®Google Scholar
• Hirshon JM, Warner M, Irvin CB, et al. Research using emergency department-related data sets: current status and future directions. Acad Emerg Med. 2009;16(11):1103–1109.
   PubMed Web of Science ®Google Scholar
• Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol. 2014;47(2):244–250.
   PubMed Web of Science ®Google Scholar
• Yun J, Yoon KS, Lee TH, et al. Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition. Toxicol Res (Camb). 2016;5(6):1663–1671.
   PubMed Web of Science ®Google Scholar
• Pizon AF, Yanta JH, Swartzentruber GS. The diagnostic process in medical toxicology. In: Brent J, Burkhart K, Dargan P, et al., editors. Critical care toxicology. Switzerland: Spring International Publishing; 2017. p. 29–41.
   Google Scholar
• Kato R, Ikeda N, Yabek SM, et al. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol. 1986;7(1):116–125.
   PubMed Web of Science ®Google Scholar
• Somberg JC, Preston RA, Ranade V, et al. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010;116(3):219–225.
   PubMed Web of Science ®Google Scholar
• Staudacher I, Wang L, Wan X, et al. hERG K + channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn Schmiedebergs Arch Pharmacol. 2011;383(2):119–139.
   PubMed Web of Science ®Google Scholar
• Hong HK, Park MH, Lee BH, et al. Block of the human ether-a-go-go-related gene (hERG) K + channel by the antidepressant desipramine. Biochem Biophys Res Commun. 2010;394(3):536–541.
   PubMed Web of Science ®Google Scholar
• Duncan RS, McPate MJ, Ridley JM, et al. Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochem Pharmacol. 2007;74(3):425–437.
   PubMed Web of Science ®Google Scholar
• Jo SH, Hong HK, Chong SH, et al. Clomipramine block of the hERG K + channel: accessibility to F656 and Y652. Eur J Pharmacol. 2008;592(1–3):19–25.
   PubMed Web of Science ®Google Scholar
• Vieweg WV, Wood MA. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics. 2004;45(5):371–377.
   PubMed Web of Science ®Google Scholar
• Caillier B, Pilote S, Castonguay A, et al. QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile. Fundam Clin Pharmacol. 2012;26(5):599–608.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Orengo JP, Hayashi S, et al. Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Clin Toxicol. 2013;51(10):1230–1234.
   PubMed Web of Science ®Google Scholar
• Curry SC, Kashani JS, LoVecchio F, et al. Intraventricular conduction delay after bupropion overdose. J Emerg Med. 2005;29(3):299–305.
   PubMed Web of Science ®Google Scholar
• Druteika D, Zed PJ. Cardiotoxicity following bupropion overdose. Ann Pharmacother. 2002;36(11):1791–1795.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Balit CR. Bupropion overdose: QTc prolongation and its clinical significance. Ann Pharmacother. 2003;37(7–8):999–1002.
   PubMed Web of Science ®Google Scholar
• Kraai EP, Seifert SA. Citalopram overdose: a fatal case. J Med Toxicol. 2015;11(2):232–236.
   PubMed Web of Science ®Google Scholar
• Tarabar AF, Hoffman RS, Nelson L. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. J Med Toxicol. 2008;4(2):101–105.
   PubMedGoogle Scholar
• Catalano G, Catalano MC, Epstein MA, et al. QTc interval prolongation associated with citalopram overdose: a case report and literature review. Clin Neuropharmacol. 2001;24(3):158–162.
   PubMed Web of Science ®Google Scholar
• de Gregorio C, Morabito G, Cerrito M, et al. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease. Int J Cardiol. 2011;148(2):226–228.
   PubMed Web of Science ®Google Scholar
• Mohammed R, Norton J, Geraci SA, et al. Prolonged QTc interval due to escitalopram overdose. J Miss State Med Assoc. 2010;51(12):350–353.
   PubMedGoogle Scholar
• Singh P, Maldonado-Duran JM. Drug-induced QT prolongation as a result of an escitalopram overdose in a patient with previously undiagnosed congenital long QT syndrome. Case Rep Med. 2014;2014:917846.
   PubMedGoogle Scholar
• Schreffler SM, Marraffa JM, Stork CM, et al. Sodium channel blockade with QRS widening after an escitalopram overdose. Pediatr Emerg Care. 2013;29(9):998–1001.
   PubMed Web of Science ®Google Scholar
• van Gorp F, Whyte IM, Isbister GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med. 2009;54(3):404–408.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42(3):277–285.
   PubMed Web of Science ®Google Scholar
• Suessbrich H, Schönherr R, Heinemann SH, et al. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol. 1997;120(5):968–974.
   PubMed Web of Science ®Google Scholar
• Osypenko VM, Degtiar V. Naid’onov VG, Shuba I. [Blockade of HERG K. + channels expressed in Xenopus oocytes by antipsychotic agents]. Fiziol Zh. 2001;47(1):17–25.
   PubMedGoogle Scholar
• Kriwisky M, Perry GY, Tarchitsky D, et al. Haloperidol-induced torsades de pointes. Chest. 1990;98(2):482–484.
   PubMed Web of Science ®Google Scholar
• O'Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother. 1999;33(10):1046–1050.
   PubMed Web of Science ®Google Scholar
• Perrault LP, Denault AY, Carrier M, et al. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth. 2000;47(3):251–254.
   PubMed Web of Science ®Google Scholar
• Khan Q, Ismail M, Haider I, et al. Prevalence of QT interval prolonging drug-drug interactions in psychiatric wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study. Int J Clin Pharm. 2017;39(6):1256–1264.
   PubMed Web of Science ®Google Scholar
• Berling I, Isbister GK. Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram. Ann Emerg Med. 2015;66(2):154–164.
   PubMed Web of Science ®Google Scholar
• Ko J-S, Guo S, Hassel J, et al. Odansetron blocks wild-type and p.F503L variant small-conductance Ca2+-activated K + channels. Am J Physiol Heart Circ Physiol. 2018;315(2):H375–H388.
   PubMed Web of Science ®Google Scholar
• George M, Al-Duaij N, O’Donnell KA, et al. Obtundation and seizure following ondansetron overdose in an infant. Clin Toxicol. 2008;46(10):1064–1066.
   Web of Science ®Google Scholar
• Moffett PM, Cartwright L, Grossart EA, et al. Intravenous ondansetron and the QT intervalin adult emergency department patients: an observational study. Acad Emerg Med. 2016;23(1):102–105.
   PubMed Web of Science ®Google Scholar
• Trivedi S, Schiltz B, Kanipakam R, et al. Effect of ondansetron on QT interval in patients cared for in the PICU. Pediatr Crit Care Med. 2016;17(7):e317–e323.
   PubMed Web of Science ®Google Scholar
• Armahizer MJ, Seybert AL, Smithburger PL, et al. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care. 2013;28(3):243–249.
   PubMed Web of Science ®Google Scholar
• Aronson MD, Hafez H. A case of trazodone-induce vetrnicular tachycardia. J Clin Psychiatry. 1986;47(7):388–389.
   PubMed Web of Science ®Google Scholar
• Winkler D, Ortner R, Pjrek E, et al. Trazodone-induced cardiac arrhythmias: a report of two cases. Hum Psychopharmacol. 2006;21(1):61–62.
   PubMed Web of Science ®Google Scholar
• Service JA, Waring WS. Qt prolongation and delayed atrioventricular conduction caused by acute ingestion of trazodone. Clin Toxicol. 2008;46(1):71–73.
   PubMed Web of Science ®Google Scholar
• de Meester A, Carbutti G, Gabriel L, et al. Fatal overdose with trazodone: case report and literature review. Acta Clin Belg. 2001;56(4):258–261.
   PubMed Web of Science ®Google Scholar
• Lee S, Lee HA, Kim SJ, et al. Cellular mechanisms for trazodone-induced cardiotoxicity. Hum Exp Toxicol. 2016;35(5):501–510.
   PubMed Web of Science ®Google Scholar
• Von Der Haar J, Talebi S, Ghobadi F, et al. Synthetic cannabinoids and their effects on the cardiovascular system. J Emerg Med. 2016;50(2):258–262.
   PubMed Web of Science ®Google Scholar
• Roose SP, Nurnberger JI, Dunner DL, et al. Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry. 1979;136(6):804–806.
   PubMed Web of Science ®Google Scholar
• Mehta N, Vannozzi R. Lithium-induced electrocardiographic changes: a complete review. Clin Cardiol. 2017;40(12):1363–1367.
   PubMed Web of Science ®Google Scholar
• Stringer J, Welsh C, Tommasello A. Methadone-associated Q-T interval prolongation and torsades de pointes. Am J Health Syst Pharm. 2009;66(9):825–833.
   PubMed Web of Science ®Google Scholar
• Farsi D, Mirafzal A, Hassanian-Moghaddam H, et al. The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose. Cardiovasc Toxicol. 2014;14(4):358–367.
   PubMed Web of Science ®Google Scholar
• Wong SC, Roberts JR. Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation. J Med Toxicol. 2007;3(4):190–194.
   PubMedGoogle Scholar
• Petersen AB, Andersen SE, Christensen M, et al. Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care. Clin Toxicol. 2014;52(1):39–43.
   Web of Science ®Google Scholar
• Othong R, Wattanasansomboon S, Kruutsaha T, et al. Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes. Clin Toxicol. 2019;57(4):234–239.
   PubMed Web of Science ®Google Scholar